These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31126309)

  • 1. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
    Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
    Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association.
    Pham TH; Bak Y; Oh JW; Hong J; Lee S; Hong JT; Yoon DY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells.
    Park HM; Park JY; Kim NY; Kim J; Pham TH; Hong JT; Yoon DY
    Biofactors; 2024; 50(2):294-310. PubMed ID: 37658685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
    Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
    Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-32θ downregulates CCL5 expression through its interaction with PKCδ and STAT3.
    Bak Y; Kang JW; Kim MS; Park YS; Kwon T; Kim S; Hong J; Yoon DY
    Cell Signal; 2014 Dec; 26(12):3007-15. PubMed ID: 25280942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
    Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
    Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells.
    Pham TH; Park HM; Kim J; Hong JT; Yoon DY
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
    Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
    Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
    Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
    Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1.
    Kim MS; Kang JW; Park YS; Lee DH; Bak Y; Kwon T; Yoon DY
    Oncotarget; 2015 Feb; 6(6):4394-405. PubMed ID: 25726525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanism of macrophages derived from PGRN gene knockout mice inhibit invasion and migration of breast cancer cells].
    Yue S; Gan D; Qian H; Zhou T; Zhang D; Shi H; Fang W; Yao M; Chen T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Sep; 35(9):769-775. PubMed ID: 31750816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Human IL-32θ Induces Polarization Into M1-like Macrophage in Human Monocytic Cells.
    Park HM; Park JY; Kim NY; Kim H; Kim HG; Son DJ; Hong JT; Yoon DY
    Immune Netw; 2024 Jun; 24(3):e27. PubMed ID: 38974209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of CCL18 antagonist blocking breast cancer metastasis.
    Liu Y; Zheng H; Li Q; Li S; Lai H; Song E; Li D; Chen J
    Clin Exp Metastasis; 2019 Jun; 36(3):243-255. PubMed ID: 31062206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
    Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
    Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
    Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
    Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling.
    Rego SL; Helms RS; Dréau D
    Angiogenesis; 2014 Jul; 17(3):573-85. PubMed ID: 24197832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
    Lin X; Chen L; Yao Y; Zhao R; Cui X; Chen J; Hou K; Zhang M; Su F; Chen J; Song E
    Oncotarget; 2015 Aug; 6(24):20485-99. PubMed ID: 26244871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3β and MyD88/NF-κB signalling pathways.
    Liu JH; Chen C; Li ZY; Zou ZM; Gao DC; Zhang X; Kuang XW; Sun ZH; Zheng WJ; Zhou P; Sun SR
    Exp Cell Res; 2020 Sep; 394(2):112157. PubMed ID: 32610185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
    Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation.
    Nie Y; Chen J; Huang D; Yao Y; Chen J; Ding L; Zeng J; Su S; Chao X; Su F; Yao H; Hu H; Song E
    Cancer Res; 2017 Jul; 77(13):3605-3618. PubMed ID: 28512246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.